{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:51:52Z","timestamp":1791161512196,"version":"4.1.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":119,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","award":["1401-4-99-25244"],"award-info":[{"award-number":["1401-4-99-25244"]}],"id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-026-01711-6","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T18:16:17Z","timestamp":1780942577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical symptoms and cognitive functioning following adjunctive N-acetylcysteine in obsessive-compulsive disorder: a double-blind, placebo-controlled trial"],"prefix":"10.1038","volume":"6","author":[{"given":"Sanaz","family":"Askari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8762-2184","authenticated-orcid":false,"given":"Shayan","family":"Eghdami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahla","family":"Tavasoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Vahid","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoomeh","family":"Yarahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atefeh","family":"Ghanbari Jolfaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Shirazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soode","family":"Tajik Esmaeeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4536-3441","authenticated-orcid":false,"given":"Mohammadreza","family":"Shalbafan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"1711_CR1","doi-asserted-by":"crossref","unstructured":"Stein, D. J. et al. Obsessive-compulsive Disorder in the World Mental Health Surveys (Research square, 2025).","DOI":"10.21203\/rs.3.rs-6090427\/v1"},{"key":"1711_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/10401230500295305","volume":"17","author":"MC Mancebo","year":"2005","unstructured":"Mancebo, M. C., Eisen, J. L., Grant, J. E. & Rasmussen, S. A. Obsessive compulsive personality disorder and obsessive compulsive disorder: clinical characteristics, diagnostic difficulties, and treatment. Ann. Clin. Psychiatry 17, 197\u2013204 (2005).","journal-title":"Ann. Clin. Psychiatry"},{"key":"1711_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1467385","volume":"12","author":"D Liu","year":"2024","unstructured":"Liu, D. et al. Time trends in anxiety disorders incidence across the BRICS: an age-period-cohort analysis for the GBD 2021. Front. Public Health 12, 1467385 (2024).","journal-title":"Front. Public Health"},{"key":"1711_CR4","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.euroneuro.2015.12.033","volume":"26","author":"CM Gillan","year":"2016","unstructured":"Gillan, C. M., Robbins, T. W., Sahakian, B. J., van den Heuvel, O. A. & van Wingen, G. The role of habit in compulsivity. Eur. Neuropsychopharmacol. 26, 828\u2013840 (2016).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"1711_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-47931-x","volume":"13","author":"N Eissazade","year":"2023","unstructured":"Eissazade, N. et al. Efficacy and safety of 5-hydroxytryptamine-3 (5-HT3) receptor antagonists in augmentation with selective serotonin reuptake inhibitors (SSRIs) in the treatment of moderate to severe obsessive\u2013compulsive disorder: a systematic review and meta-analysis of randomized clinical trials. Sci. Rep. 13, 20837 (2023).","journal-title":"Sci. Rep."},{"key":"1711_CR6","unstructured":"Wilson, M. & Tripp, J. Clomipramine (StatPearls Publishing, 2024)."},{"key":"1711_CR7","first-page":"225","volume":"2","author":"M Fitri","year":"2024","unstructured":"Fitri, M. & Ardi, Z. The use of cognitive behavioral therapy (CBT) to reduce obsessive compulsive disorder (OCD) behavior. J. Psychol. Counsel. Educ. 2, 225\u2013235 (2024).","journal-title":"J. Psychol. Counsel. Educ."},{"key":"1711_CR8","doi-asserted-by":"crossref","unstructured":"Trent, E. S., Zhou, R. J., Mammo, L., Goodman, W. K. & Storch, E. A. High intensity approaches to exposure and response prevention for obsessive-compulsive disorder. Behav. Brain Res. 481, 115427 (2025).","DOI":"10.1016\/j.bbr.2025.115427"},{"key":"1711_CR9","first-page":"239","volume":"80","author":"JN Fenske","year":"2009","unstructured":"Fenske, J. N. & Schwenk, T. L. Obsessive compulsive disorder: diagnosis and management. Am. Fam. Physician 80, 239\u2013245 (2009).","journal-title":"Am. Fam. Physician"},{"key":"1711_CR10","doi-asserted-by":"publisher","first-page":"19ac13182","DOI":"10.4088\/JCP.19ac13182","volume":"81","author":"RR Kayser","year":"2020","unstructured":"Kayser, R. R. Pharmacotherapy for treatment-resistant obsessive-compulsive disorder.  J. Clin. psychiatry 81, 19ac13182 (2020).","journal-title":"J. Clin. psychiatry"},{"key":"1711_CR11","doi-asserted-by":"publisher","first-page":"676","DOI":"10.9758\/cpn.23.1075","volume":"21","author":"D Roh","year":"2023","unstructured":"Roh, D., Jang, K. W. & Kim, C.-H. Clinical advances in treatment strategies for obsessive-compulsive disorder in adults. Clin. Psychopharmacol. Neurosci. 21, 676 (2023).","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"1711_CR12","first-page":"281","volume":"101","author":"A Okasha","year":"2000","unstructured":"Okasha, A. et al. Cognitive dysfunction in obsessive-compulsive disorder. Acta Psychiatr. Scand. 101, 281\u2013285 (2000).","journal-title":"Acta Psychiatr. Scand."},{"key":"1711_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1037\/0894-4105.20.4.409","volume":"20","author":"NS Lawrence","year":"2006","unstructured":"Lawrence, N. S. et al. Decision making and set shifting impairments are associated with distinct symptom dimensions in obsessive-compulsive disorder. Neuropsychology 20, 409 (2006).","journal-title":"Neuropsychology"},{"key":"1711_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-013-0357-4","volume":"15","author":"AW Calkins","year":"2013","unstructured":"Calkins, A. W., Berman, N. C. & Wilhelm, S. Recent advances in research on cognition and emotion in OCD: a review. Curr. psychiatry Rep. 15, 357 (2013).","journal-title":"Curr. psychiatry Rep."},{"key":"1711_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5480391","volume":"2016","author":"M Sayyah","year":"2016","unstructured":"Sayyah, M., Eslami, K., AlaiShehni, S. & Kouti, L. Cognitive function before and during treatment with selective serotonin reuptake inhibitors in patients with depression or obsessive-compulsive disorder. Psychiatry J. 2016, 5480391 (2016).","journal-title":"Psychiatry J."},{"key":"1711_CR16","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1176\/appi.ajp.2020.19030331","volume":"177","author":"PS Boedhoe","year":"2020","unstructured":"Boedhoe, P. S. et al. Subcortical brain volume, regional cortical thickness, and cortical surface area across disorders: findings from the ENIGMA ADHD, ASD, and OCD working groups. Am. J. Psychiatry 177, 834\u2013843 (2020).","journal-title":"Am. J. Psychiatry"},{"key":"1711_CR17","doi-asserted-by":"publisher","first-page":"568","DOI":"10.5498\/wjp.v11.i9.568","volume":"11","author":"A Maraone","year":"2021","unstructured":"Maraone, A., Tarsitani, L., Pinucci, I. & Pasquini, M. Antiglutamatergic agents for obsessive-compulsive disorder: where are we now and what are possible future prospects? World J. Psychiatry 11, 568 (2021).","journal-title":"World J. Psychiatry"},{"key":"1711_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1421150","volume":"15","author":"S Eghdami","year":"2024","unstructured":"Eghdami, S. et al. The safety and efficacy of N-acetylcysteine as an augmentation in the treatment of obsessive-compulsive disorder in adults: a systematic review and meta-analysis of randomized clinical trials. Front Psychiatry 15, 1421150 (2024).","journal-title":"Front Psychiatry"},{"key":"1711_CR19","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1097\/MS9.0000000000001890","volume":"86","author":"S Eghdami","year":"2024","unstructured":"Eghdami, S., Afrashteh, F., Shojaii, A., Abolhasani, M. & Motevalian, M. The therapeutic effect of alcoholic extract of Fumaria parviflora on high-fat diet-induced nonalcoholic fatty liver in rats: an animal experiment. Ann. Med. Surg. 86, 2657\u20132664 (2024).","journal-title":"Ann. Med. Surg."},{"key":"1711_CR20","doi-asserted-by":"crossref","unstructured":"Meyer, J. Inflammation, obsessive-compulsive disorder, and related disorders. Curr. Top. Behav. Neurosci. 49, 31\u201353 (2021).","DOI":"10.1007\/7854_2020_210"},{"key":"1711_CR21","doi-asserted-by":"publisher","first-page":"5450","DOI":"10.7150\/ijbs.97723","volume":"20","author":"H-B Kim","year":"2024","unstructured":"Kim, H.-B. et al. N-acetylcysteine alleviates depressive-like behaviors in adolescent EAAC1-\/-mice and early life stress model rats. Int. J. Biol. Sci. 20, 5450 (2024).","journal-title":"Int. J. Biol. Sci."},{"key":"1711_CR22","doi-asserted-by":"crossref","unstructured":"Pangrazzi, L. et al. The interplay between oxidative stress and inflammation supports autistic-related behaviors in mice. bioRxiv, https:\/\/www.biorxiv.org\/content\/10.1101\/2023.09.11.557109v1.full (2023).","DOI":"10.1101\/2023.09.11.557109"},{"key":"1711_CR23","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.3390\/ijerph19116370","volume":"19","author":"DK Lee","year":"2022","unstructured":"Lee, D. K. & Lipner, S. R. The potential of N-acetylcysteine for treatment of trichotillomania, excoriation disorder, onychophagia, and onychotillomania: an updated literature review. Int. J. Environ. Res. Public Health 19, 6370 (2022).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"1711_CR24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s40263-022-00907-3","volume":"36","author":"RC Bradlow","year":"2022","unstructured":"Bradlow, R. C., Berk, M., Kalivas, P. W., Back, S. E. & Kanaan, R. A. The potential of N-acetyl-L-cysteine (NAC) in the treatment of psychiatric disorders. CNS drugs 36, 451\u2013482 (2022).","journal-title":"CNS drugs"},{"key":"1711_CR25","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1089\/neur.2023.0124","volume":"5","author":"S Khasnavis","year":"2024","unstructured":"Khasnavis, S., Belliveau, T., Arnsten, A. & Fesharaki-Zadeh, A. Combined use of guanfacine and N-acetylcysteine for the treatment of cognitive deficits after traumatic brain injury. Neurotrauma Rep. 5, 226\u2013231 (2024).","journal-title":"Neurotrauma Rep."},{"key":"1711_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1282198","volume":"15","author":"F Vedaei","year":"2024","unstructured":"Vedaei, F. et al. Treatment effects of N-acetyl cysteine on resting-state functional MRI and cognitive performance in patients with chronic mild traumatic brain injury: a longitudinal study. Front. Neurol. 15, 1282198 (2024).","journal-title":"Front. Neurol."},{"key":"1711_CR27","unstructured":"Harm, M., Hope, M. & Household, A. Diagnostic and Statistical Manual of Mental Disorders, 5th edn (American Psychiatric Association 2013) www.lancaster.ac.uk.Arya."},{"key":"1711_CR28","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/wps.20984","volume":"21","author":"M Cervin","year":"2022","unstructured":"Cervin, M. et al. Empirical severity benchmarks for obsessive-compulsive disorder across the lifespan. World Psychiatry 21, 315\u2013316 (2022).","journal-title":"World Psychiatry"},{"key":"1711_CR29","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.psychres.2016.08.028","volume":"245","author":"S Asadi","year":"2016","unstructured":"Asadi, S. et al. Exploring yale-brown obsessive-compulsive scale symptom structure in Iranian OCD patients using item-based factor analysis. Psychiatry Res. 245, 416\u2013422 (2016).","journal-title":"Psychiatry Res."},{"key":"1711_CR30","first-page":"677","volume":"4","author":"A Puente","year":"1985","unstructured":"Puente, A. Wisconsin card sorting test. Test. Crit. 4, 677\u2013682 (1985).","journal-title":"Test. Crit."},{"key":"1711_CR31","doi-asserted-by":"crossref","unstructured":"Brickenkamp, R. & Zillmer, E. The d2 test of attention (1st USA ed.). (Hogrefe & Huber Pub., 1998).","DOI":"10.1037\/t03299-000"},{"key":"1711_CR32","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/YIC.0000000000000321","volume":"35","author":"F Yousefzadeh","year":"2020","unstructured":"Yousefzadeh, F. et al. 5-Hydroxytryptophan as adjuvant therapy in treatment of moderate to severe obsessive-compulsive disorder: a double-blind randomized trial with placebo control. Int. Clin. Psychopharmacol. 35, 254\u2013262 (2020).","journal-title":"Int. Clin. Psychopharmacol."},{"key":"1711_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-021-03642-z","volume":"22","author":"S Askari","year":"2022","unstructured":"Askari, S. et al. Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial. BMC Psychiatry 22, 34 (2022).","journal-title":"BMC Psychiatry"},{"key":"1711_CR34","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","volume":"41","author":"F Faul","year":"2009","unstructured":"Faul, F., Erdfelder, E., Buchner, A. & Lang, A.-G. Statistical power analyses using G* Power 3.1: Tests for correlation and regression analyses. Behav. Res. methods 41, 1149\u20131160 (2009).","journal-title":"Behav. Res. methods"},{"key":"1711_CR35","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/biomet\/52.3-4.591","volume":"52","author":"SS Shapiro","year":"1965","unstructured":"Shapiro, S. S. & Wilk, M. B. An analysis of variance test for normality (complete samples). Biometrika 52, 591\u2013611 (1965).","journal-title":"Biometrika"},{"key":"1711_CR36","doi-asserted-by":"crossref","unstructured":"Mann, H. B. & Whitney, D. R. On a test of whether one of two random variables is stochastically larger than the other. Ann. Math. Stat. 18, 50\u201360 (1947).","DOI":"10.1214\/aoms\/1177730491"},{"key":"1711_CR37","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1214\/aoms\/1177731915","volume":"11","author":"JW Mauchly","year":"1940","unstructured":"Mauchly, J. W. Significance test for sphericity of a normal n-variate distribution.  Ann. Math. Stat. 11, 204\u2013209 (1940).","journal-title":"Ann. Math. Stat."},{"key":"1711_CR38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/BF02289823","volume":"24","author":"SW Greenhouse","year":"1959","unstructured":"Greenhouse, S. W. & Geisser, S. On methods in the analysis of profile data. Psychometrika 24, 95\u2013112 (1959).","journal-title":"Psychometrika"},{"key":"1711_CR39","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1037\/1082-989X.7.2.147","volume":"7","author":"JL Schafer","year":"2002","unstructured":"Schafer, J. L. & Graham, J. W. Missing data: our view of the state of the art. Psychol. Methods 7, 147 (2002).","journal-title":"Psychol. Methods"},{"key":"1711_CR40","unstructured":"Field, A. Discovering Statistics using IBM SPSS Statistics (Sage publications limited; 2024)."},{"key":"1711_CR41","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1177\/009286150103500418","volume":"35","author":"CH Mallinckrodt","year":"2001","unstructured":"Mallinckrodt, C. H., Clark, W. S. & David, S. R. Type I error rates from mixed effects model repeated measures versus fixed effects ANOVA with missing values imputed via last observation carried forward. Drug Inf. J. 35, 1215\u20131225 (2001).","journal-title":"Drug Inf. J."},{"key":"1711_CR42","first-page":"9780470316696","volume":"10","author":"R Little","year":"1987","unstructured":"Little, R. & Rubin, D. Multiple imputation for nonresponse in surveys. Wiley 10, 9780470316696 (1987).","journal-title":"Wiley"},{"key":"1711_CR43","doi-asserted-by":"crossref","unstructured":"West B. T., Welch K. B. & Galecki A. T. Linear Mixed Models: A Practical Guide using Statistical Software (Chapman and Hall\/CRC; 2022).","DOI":"10.1201\/9781003181064"},{"key":"1711_CR44","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1038\/npp.2013.150","volume":"38","author":"CI Rodriguez","year":"2013","unstructured":"Rodriguez, C. I. et al. Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept. Neuropsychopharmacology 38, 2475\u20132483 (2013).","journal-title":"Neuropsychopharmacology"},{"key":"1711_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1329748","volume":"15","author":"W Hassan","year":"2024","unstructured":"Hassan, W. et al. Variations in obsessive compulsive disorder symptomatology across cultural dimensions. Front. Psychiatry 15, 1329748 (2024).","journal-title":"Front. Psychiatry"},{"key":"1711_CR46","doi-asserted-by":"publisher","DOI":"10.1017\/S1754470X2500008X","volume":"18","author":"C Mogan","year":"2025","unstructured":"Mogan, C. et al. An outcome study of an intensive, out-patient exposure and response prevention therapy for obsessive compulsive disorder.  Cogn. Behav. Therapist 18, e21 (2025).","journal-title":"Cogn. Behav. Therapist"},{"key":"1711_CR47","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/YIC.0000000000000068","volume":"30","author":"EA Voss","year":"2015","unstructured":"Voss, E. A., Ryan, P. B., Stang, P. E., Hough, D. & Alphs, L. Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics: analysis of a Medicaid claims database. Int. Clin. Psychopharmacol. 30, 151\u2013157 (2015).","journal-title":"Int. Clin. Psychopharmacol."},{"key":"1711_CR48","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1001\/jama.2010.39","volume":"303","author":"BR Hemmelgarn","year":"2010","unstructured":"Hemmelgarn, B. R. et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA 303, 423\u2013429 (2010).","journal-title":"JAMA"},{"key":"1711_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1590\/2176-9451.19.4.027-029.ebo","volume":"19","author":"J Faber","year":"2014","unstructured":"Faber, J. & Fonseca, L. M. How sample size influences research outcomes. Dent. Press J. Orthod. 19, 27\u201329 (2014).","journal-title":"Dent. Press J. Orthod."},{"key":"1711_CR50","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jad.2015.03.008","volume":"178","author":"Y Zhu","year":"2015","unstructured":"Zhu, Y. et al. Decreased thalamic glutamate level in unmedicated adult obsessive\u2013compulsive disorder patients detected by proton magnetic resonance spectroscopy. J. Affect. Disord. 178, 193\u2013200 (2015).","journal-title":"J. Affect. Disord."},{"key":"1711_CR51","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.3390\/life15101585","volume":"15","author":"S Eghdami","year":"2025","unstructured":"Eghdami, S., Saeidi, M., Gunturu, S., Boroon, M. & Shalbafan, M. Gut microbiota and obsessive\u2013compulsive disorder: a systematic review of mechanistic links, evidence from human and preclinical studies, and therapeutic prospects. Life 15, 1585 (2025).","journal-title":"Life"},{"key":"1711_CR52","doi-asserted-by":"crossref","unstructured":"Baker, D. A. et al. Contribution of cystine\u2013glutamate antiporters to the psychotomimetic effects of phencyclidine. Neuropsychopharmacology 33, 1760\u201372 (2008).","DOI":"10.1038\/sj.npp.1301532"},{"key":"1711_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-021-00534-6","volume":"22","author":"F Hadi","year":"2021","unstructured":"Hadi, F., Kashefinejad, S., Kamalzadeh, L., Hoobehfekr, S. & Shalbafan, M. Glutamatergic medications as adjunctive therapy for moderate to severe obsessive-compulsive disorder in adults: a systematic review and meta-analysis. BMC Pharmacol. Toxicol. 22, 69 (2021).","journal-title":"BMC Pharmacol. Toxicol."},{"key":"1711_CR54","doi-asserted-by":"publisher","first-page":"977","DOI":"10.2174\/1570159X15666170320104237","volume":"15","author":"Z Marinova","year":"2017","unstructured":"Marinova, Z., Chuang, D.-M. & Fineberg, N. Glutamate-modulating drugs as a potential therapeutic strategy in obsessive-compulsive disorder. Curr. Neuropharmacol. 15, 977\u2013995 (2017).","journal-title":"Curr. Neuropharmacol."},{"key":"1711_CR55","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3928\/00485713-20150602-06","volume":"45","author":"C Pittenger","year":"2015","unstructured":"Pittenger, C. Glutamate modulators in the treatment of obsessive-compulsive disorder. Psychiatr. Ann. 45, 308\u2013315 (2015).","journal-title":"Psychiatr. Ann."},{"key":"1711_CR56","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1177\/0269881119878177","volume":"33","author":"M Shalbafan","year":"2019","unstructured":"Shalbafan, M. et al. Fluvoxamine combination therapy with tropisetron for obsessive-compulsive disorder patients: a placebo-controlled, randomized clinical trial. J. Psychopharmacol. 33, 1407\u20131414 (2019).","journal-title":"J. Psychopharmacol."},{"key":"1711_CR57","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.biopsych.2012.06.015","volume":"73","author":"T Hajek","year":"2013","unstructured":"Hajek, T. et al. Brain structural signature of familial predisposition for bipolar disorder: replicable evidence for involvement of the right inferior frontal gyrus. Biol. psychiatry 73, 144\u2013152 (2013).","journal-title":"Biol. psychiatry"},{"key":"1711_CR58","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1192\/apt.bp.109.007237","volume":"17","author":"N Fineberg","year":"2011","unstructured":"Fineberg, N. & Brown, A. Pharmacotherapy for obsessive\u2014compulsive disorder. Adv. Psychiatr. Treat. 17, 419\u2013434 (2011).","journal-title":"Adv. Psychiatr. Treat."},{"key":"1711_CR59","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1080\/13854046.2012.680913","volume":"26","author":"M Calamia","year":"2012","unstructured":"Calamia, M., Markon, K. & Tranel, D. Scoring higher the second time around: meta-analyses of practice effects in neuropsychological assessment.  Clin. Neuropsychologist 26, 543\u2013570 (2012).","journal-title":"Clin. Neuropsychologist"},{"key":"1711_CR60","doi-asserted-by":"crossref","unstructured":"Kirk, R. E. The importance of effect magnitude. In Handbook of Research Methods in Experimental Psychology (ed. Davis, S. F.) 83\u2013105 (Blackwell Publishing Ltd, 2003).","DOI":"10.1002\/9780470756973.ch5"},{"key":"1711_CR61","doi-asserted-by":"publisher","first-page":"287","DOI":"10.32598\/bcn.2022.1604.3","volume":"15","author":"F Bakizadeh","year":"2024","unstructured":"Bakizadeh, F. et al. Cognitive rehabilitation for adult patients with obsessive-compulsive disorder: a systematic review of randomized controlled trials. Basic Clin. Neurosci. 15, 287\u2013300 (2024).","journal-title":"Basic Clin. Neurosci."},{"key":"1711_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.729757","volume":"15","author":"F Franzoni","year":"2021","unstructured":"Franzoni, F. et al. Oxidative stress and cognitive decline: the neuroprotective role of natural antioxidants. Front. Neurosci. 15, 729757 (2021).","journal-title":"Front. Neurosci."},{"key":"1711_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.829090","volume":"13","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. The effects of enriched rehabilitation on cognitive function and serum glutamate levels post-stroke. Front Neurol. 13, 829090 (2022).","journal-title":"Front Neurol."},{"key":"1711_CR64","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1080\/00273170802285941","volume":"43","author":"L Wang","year":"2008","unstructured":"Wang, L., Zhang, Z., McArdle, J. J. & Salthouse, T. A. Investigating ceiling effects in longitudinal data analysis. Multivar. Behav. Res. 43, 476\u2013496 (2008).","journal-title":"Multivar. Behav. Res."},{"key":"1711_CR65","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1177\/014662168801200410","volume":"12","author":"J Cohen","year":"1988","unstructured":"Cohen, J. Set correlation and contingency tables. Appl. Psychol. Meas. 12, 425\u2013434 (1988).","journal-title":"Appl. Psychol. Meas."},{"key":"1711_CR66","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1017\/S135561770410307X","volume":"10","author":"ME Bates","year":"2004","unstructured":"Bates, M. E. & Lemay, E. P. The d2 Test of Attention: Construct validity and extensions in scoring techniques. J. Int. Neuropsychol. Soc. 10, 392\u2013400 (2004).","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"1711_CR67","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.tics.2008.07.005","volume":"12","author":"F Verbruggen","year":"2008","unstructured":"Verbruggen, F. & Logan, G. D. Response inhibition in the stop-signal paradigm. Trends Cogn. Sci. 12, 418\u2013424 (2008).","journal-title":"Trends Cogn. Sci."},{"key":"1711_CR68","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.tics.2010.11.004","volume":"15","author":"A Etkin","year":"2011","unstructured":"Etkin, A., Egner, T. & Kalisch, R. Emotional processing in anterior cingulate and medial prefrontal cortex. Trends Cogn. Sci. 15, 85\u201393 (2011).","journal-title":"Trends Cogn. Sci."},{"key":"1711_CR69","doi-asserted-by":"publisher","first-page":"e000017","DOI":"10.1136\/bmjmed-2021-000017","volume":"1","author":"CF Johnson","year":"2022","unstructured":"Johnson, C. F., Maxwell, M., Williams, B., Dougall, N. & MacGillivray, S. Dose-response effects of selective serotonin reuptake inhibitor monotherapy for the treatment of depression: systematic review of reviews and meta-narrative synthesis. BMJ Med. 1, e000017 (2022).","journal-title":"BMJ Med."},{"key":"1711_CR70","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.biopsych.2008.04.022","volume":"64","author":"M Berk","year":"2008","unstructured":"Berk, M. et al. N-acetyl cysteine for depressive symptoms in bipolar disorder\u2014a double-blind randomized placebo-controlled trial. Biol. Psychiatry 64, 468\u2013475 (2008).","journal-title":"Biol. Psychiatry"},{"key":"1711_CR71","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00127-023-02503-2","volume":"58","author":"S Eghdami","year":"2023","unstructured":"Eghdami, S., Ahmadkhaniha, H. R., Baradaran, H. R. & Hirbod-Mobarakeh, A. Ecological momentary interventions for smoking cessation: a systematic review and meta-analysis. Soc. Psychiatry Psychiatr. Epidemiol. 58, 1431\u20131445 (2023).","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"1711_CR72","doi-asserted-by":"crossref","unstructured":"Hirbod-Mobarakeh, A. et al. Ecological momentary interventions for bipolar disorder: a systematic review and meta-analysis. Soc. Psychiatry Psychiatric Epidemiol. 61, 587\u2013601 (2026).","DOI":"10.1007\/s00127-025-02845-z"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01711-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01711-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01711-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:02:54Z","timestamp":1791158574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01711-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1711"],"URL":"https:\/\/doi.org\/10.1038\/s43856-026-01711-6","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"515"}}